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Sudden demise of a healthy fetus or a neonate is a very tragic episode in the life of 
parents. These deaths have been a mystery since ages but still remain unexplained. 
This review proposes the involvement of trigeminal nerve, neurotransmitter substance 
P (SP), and its receptor neurokinin 1 (NK-1R) in regulation of cardiorespiratory control in 
fetuses and newborns. Anomalies and immaturity of neuroregulatory systems such as 
trigeminal system in medulla oblongata of brainstem may provide a possible mechanism 
of sudden perinatal deaths. Vulnerable infants are born with respiratory center immaturity 
which in combination with any stressor such as cold, hypoxia, and smoking may lead 
to cessation of breathing and ventilatory response. SP/NK-1R may be involved in 
regulating the ventilatory control in neonates while it is decreased in fetal and adult life 
in humans, and any alterations from these may lead to irreversible sleep apnea and 
fatal breathing, ultimately sudden death. This review summarizes the studies performed 
to highlight the expression of SP or NK-1R in sudden perinatal deaths and proposes 
the involvement of trigeminal ganglion along with its nerve and SP/NK-1R expression 
alteration as one of the possible pathophysiological underlying mechanism. However, 
further studies are required to explore the role of SP, NK-1R, and trigeminal system in 
the pathogenesis of sudden infant deaths, sudden intrauterine deaths, stillbirths, and 
sudden deaths later in human life.
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iNTRODUCTiON
Sudden perinatal deaths comprise of stillbirths, fetal [sudden unexplained intrauterine deaths 
(SUID)], and infant death [less than 1 year of age, sudden infant deaths (SIDS)] that is spontaneous 
and mysterious. These cases remain unresolved even after complete autopsy, medical examination, 
and thorough investigation of death scene (1). Theories on the possible causes of SIDS are more than 
100. It is widely accepted that SIDS is a combination of multifactors that occur during the period 
of increased vulnerability and may cause the fatal outcome in some infant (2). Bergman et al. also 
suggested that SIDS is not caused by “single characteristic that ordains an infant for death,” but 
depends on an “interaction of risk factors with variable probabilities” (3). Pathophysiology of SIDS 
remains unexplained (2).
Brainstem anomalies as a possible cause of sudden perinatal death is mostly accepted hypothesis 
as suggested by Filiano and Kinney (4) in their famous triple risk model. These neuropathologies 
lead to vulnerable fetus or newborn who becomes unable to respond to any kind of stressor and 
dies suddenly (5). All the factors whether maternal, infant, environmental, or genetic interfere with 
FiGURe 1 | Processing of nociceptive stimulus within brain.
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the cardiorespiratory control leading to final common pathway 
(death) (6). Mechanisms underlying SIDS appear to originate 
in fetal period of development resulting in neural damage and 
affect breathing or blood pressure during sleep later on (5). 
Neuromodulators like somatostatin, serotonins (7), substance 
P (SP), etc. regulate the breathing control activities (8–10). The 
focus of current review is to highlight the SP and its receptor 
NK-1R in neuronal respiratory control system during critical 
ontogenetic periods of human brain development. Our research 
group for the first time in 2011 (11) suggested the involvement 
of SP in the pathogenesis of SUID.
SUBSTANCe P
Substance P is the prototype and first discovered tachykinin. 
It is a neurotransmitter of the afferent sensory nervous system 
(12). It is a small peptide hormone consisting of 11 amino 
acids belonging to tachykinin family (TK) (13). It is the most 
abundant TK peptide and neurotransmitter in CNS of mam-
mals (14). It has been implicated in various physiological and 
pathophysiological processes (15) and found in many central 
and peripheral neural pathways. SP is released from fifth cranial 
nerve, the trigeminal, which is part of trigeminal system that 
is explained below.
TRiGeMiNAL SYSTeM
Trigeminal system is highly established and well-studied system 
in mammals and birds (16). SP immunoreactivity (SP-IR) has 
been observed in trigeminal (17) and dorsal root ganglia (DRG) 
(18). Main feature of this system is the presence of two distinct 
primary afferent neuronal groups: trigeminal ganglion (TG) and 
mesencephalic trigeminal nucleus (MTN). Cell bodies of these 
primary afferent neurons are present in TG (19), and few lie 
in MTN. MTN is involved mainly in proprioception (mainly 
orofacial musculature) (20). TG dorsomedial part is involved 
in nociception, thermoreception, and proprioception while its 
ventrolateral part is involved in mechanoreception (21). Signals 
from the trigeminal system are transmitted by second order 
neurons in brainstem to different regions of CNS pain centers 
(22). The processes in the middle of ganglion end up on various 
groups of second order neurons, which convey their signals to 
the somatosensory cortex via thalamus (23) (Figure 1).
TRiGeMiNAL GANGLiON
Trigeminal ganglion is accumulation of pseudounipolar neurons 
(24) and consists of neurons and their fibers. TG is a cranial analog 
of DRG in PNS (21). Activation of TG nerves plays a central role 
in most forms of orofacial pain (25). Many neurotransmitters 
and their receptors are localized in different subpopulations of 
TG neurons (21). TG neurons supply innervations mostly to the 
mechanoreceptors, thermoreceptors, and nociceptors in orofacial 
region (16). Glial cells also known as satellite cells (26) completely 
enclose the neuronal somata of TG neurons, and thus they have 
no synaptic contacts (27).
Based on their appearance, ganglion cells are classified as 
follows: large light (A) and small dark (B) cells (28). Large light 
A cells produce thick myelinated fibers while the thin C fibers 
(both myelinated and unmyelinated) are originated from small 
dark B cells (29). Two primary afferent neuron subpopulations 
are noticed in TG: small- and medium-sized neurons with small 
somata, including glutamate, somatostatin, SP, neurokinin A, 
CGRP, cholecystokinin, vasoactive intestinal peptide, and gala-
nin, and larger sized neurons that are relatively less and include 
neuropeptide Y and peptide 19. Presence of SP in small diameter 
primary afferent fibers and in nociceptive centers of brain gives 
us an idea of its nociceptive role (30).
TRiGeMiNAL NeRve (TrN)
Trigeminal ganglion provides somatosensory innervations of 
face and oral cavity through TrN (31) (Figure 2). It has three 
branches: V1 and V2 are purely sensory while V3 has both sen-
sory and motor functions. V1 innervates forehead, upper eyelid, 
cornea, conjunctiva, mucosa of frontal ethmoid and sphenoid 
sinuses, and dorsum of nose. V2 innervates upper lip, lateral 
portions of nose, parts of oral cavity, mucosa of nasal cavity, 
maxillary sinus, upper jaw, and roof of mouth and upper dental 
arch while V3 innervates lower lip, chin, cheek, lower teeth, 
gingival, mucosa of lower jaw, floor of mouth, and anterior two-
thirds of tongue (25).
NeUROKiNiN ReCePTORS
Tachykinin receptors also known as neurokinins (NK) are 
G protein-coupled receptors, localized in the nucleus of the solitary 
FiGURe 2 | Graphical representation of trigeminal nerve nucleus.
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tract, which is known to be involved in the rhythmic control (32). 
There are three NK receptors (1R-3R). Functional activities of SP 
are initiated after binding to the neurokinin 1 (NK-1R), which is 
a transmembrane protein (33). Upon binding, a chain of signaling 
events is activated by the internalization of SP–NK-1R complex 
(34), which stimulates the second messenger phospholipase C 
resulting in the production of inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol (DAG) (35). Calcium is released intracellularly 
as a result of stimulation of endoplasmic reticulum by IP3, and 
protein kinase C is activated by DAG (36).
These neurokinin receptors are present within the cardiores-
piratory regulatory control centers and in the phrenic nucleus, 
which controls the diaphragm and mediates the respiratory 
responses to SP. Prototype TK, SP, was reported to stimulate 
the respiratory rhythm in wild-type mice, in the in vitro brain-
stem–spinal cord preparation but not in the NK-1R knockout 
(NK-1R−/−) mice (37). The study of in vitro brainstem prepara-
tions revealed that NK-Rs have a vital role in the regulation of 
respiratory control and lung burst activity during the develop-
ment of bullfrog from tadpole to adult stage (38). Role of SP has 
been implicated in the development of plasticity of respiratory 
system and the regulation of respiratory rhythm. A functional 
SP-ergic system is necessary for the generation of sufficient 
ventilatory responses to hypoxia in newborn mice and during 
early maturation (39). Under increasing hypoxia, SP manifests 
as natural anti-hypoxant and is not only involved in nociception 
mechanisms but also in brain adaptation to oxygen deficiency 
(40). SP-ergic system was found to be more active in regulating 
the respiratory responses during the early postnatal period in 
neonatal rat brainstem–spinal cord preparation (41) and medul-
lary slice preparations of newborn mice (42). But surprisingly, SP 
was not found to control ventilatory rhythm generation in fetal 
rats, and it was hypothesized that, may be, SP does not modulate 
the generation of respiratory responses before birth and affects 
the phrenic motoneurons only after birth (43).
ROLe OF SP/NK-1R iN ReGULATiON 
OF ReSPiRATORY RHYTHM
Neuromodulator SP causes dilation of vessels, contraction of 
smooth muscles in the respiratory system, increased action 
potential in neurons, an increase in vascular flow, and produc-
tion of saliva (44). In humans, NK-1R is involved in causing 
bronchoconstriction (45). NK-1Rs mediate increases in secretion 
of mucous glands in human trachea (46). SP-IR was observed to 
be potentiated in a study conducted on the bronchoalveolar lav-
age fluid (47) and sputum samples (48) from asthmatic patients. 
NK-1R mRNA expression was also higher in asthmatic lung 
tissue when compared to non-asthmatic (49). Elevated levels of 
SP and PPT-A mRNA were observed in the nodose ganglia of 
ovalbumin-sensitized guinea pigs (50) with increased neurogenic 
inflammation and bronchoconstriction produced by NK-1R (51). 
It suggests that SP/NK-1R and neurogenic immunoreactivity are 
critical for the progression of airway hyperresponsiveness (AHR) 
(52), and NK-1R antagonists attenuated the AHR and plasma 
extravasation in animal models in  vivo (51). The underlying 
mechanism in causing AHR may be the airway inflammation 
and interaction of SP and CGRP (calcitonin gene-related peptide) 
(53). Mice deficient in NK-1Rs show reduced IgG-mediated lung 
injury and neutrophil infiltration as compared to the control 
group (54). SP is present in bronchopulmonary C fibers (PCFs) 
and defend the lungs against injury from inhaled agents by a CNS 
reflex consisting of apnea, cough, bronchoconstriction, hypoten-
sion, bradycardia (55), secretion from seromucous glands, release 
of mediators (including prostaglandins and NO) from the airway 
epithelium (56), and bronchorelaxation (57). SP synthesis in vagal 
airway C fibers may be enhanced in pathological conditions such 
as allergic asthma and chronic bronchitis and may be responsible 
for some of the associated respiratory symptoms stated above 
(55). SP produces bronchoconstriction and lung resistance in 
cynomolgus monkeys (58) and sheep (59) via NK-1 receptors, 
and this effect is more pronounced when they are given by the 
intravenous route.
eviDeNCe OF iNvOLveMeNT OF SPiNAL 
TRiGeMiNAL NUCLeUS iN ReSPiRATORY 
RHYTHMiC CONTROL
Few earlier studies with small sample size have been performed 
in relation to SP expression in brainstems of SIDS (60–63). Our 
group (11) defined localization, morphology, and functional 
aspects of TrN in different developmental stages of human brain 
FiGURe 3 | Substance P (SP) expression theory (in human brainstems) 
to explain sudden perinatal deaths.
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development for the first time in cases of sudden perinatal 
death victims. This study revealed that fetuses in control 
group had no well-defined TrN as there was either weak or 
no SP expression, while in medulla oblongata sections from 
control infants, a well-defined TrN with recognizable tract was 
observed. While SP expression was depleted in SIDS victim 
brainstems showing TrN hypoplasia and enhanced in SUID 
victims. Density of SP varied from very low in fetuses to very 
high in infants, which points out to the functional requirement 
of TrN in postnatal period of human life. TrN development 
is enhanced in late developmental stages of brain, which was 
identified by enhanced SP expression. Recently, trigeminocar-
diac reflex has been suggested as an underlying mechanism for 
the pathogenesis of SIDS (7).
I have also reported in a previous computational study that 
SP/NK-1R has small protein interaction network, its gene is 
singleton, providing a possibility that it may be involved in some 
extremely crucial activities of human developmental phases, and 
any perturbation in terms of mutations in the gene can lead to 
lethal outcomes including sudden death (64). Similarly, in another 
study, I along with my colleagues observed higher expression 
of SP in oral cancer patients from Pakistani population. This 
expression was directly proportional to the grade of cancer and 
poor prognosis. This study also confirms the involvement of SP 
in nociceptive stimuli in orofacial region (65). In our previous 
study (11), we detected SP expression in medulla oblongata and 
spinal cord from early stages of human brainstem development, 
exclusively in the spinal TrN. This phenomenon exhibits that SP 
is highly specific and localized in human brain. Very few stud-
ies focus on the TrN in humans (66, 67). As spinal trigeminal 
nucleus and its tract have no definite boundaries, it is difficult 
to identify it. Nevertheless, it can be recognized by labeling it 
with SP, which is its main neurotransmitter (11). In experimental 
murine studies, TrN was observed to be involved in rhythmic 
autonomic behaviors including breathing (68, 69). These studies 
also suggested an essential role of TrN in controlling respiratory 
rhythm, and its activity was observed to be altered in respiratory 
disorders (70, 71).
Observations from a recent study by Hayashi and Sakuma (72) 
are also concordant with our observations and findings that SP 
expression was elevated in seven out of eight victims of sudden 
unexplained deaths. A previous study also suggested that SP 
containing cells in human TG is variable in different age groups; 
24% in neonates while 17% in adults (73). Study of Hayashi and 
Sakuma (72) shows expression of SP in brainstem of children and 
adults as compared to our study, which reported SP expression 
in SIDS and SUID. If we summarize the findings of both studies 
and compare them with our study also, we reach to conclusion 
that SP expression in brainstems is negligible in fetus, enhanced 
in neonates while decreased in children and adults in controls. 
While if vice versa it leads to sudden deaths (Figure 3).
CONCLUSiON
Studies suggest an important role of SP/NK-1R and trigeminal 
system during the critical neurodevelopmental periods in which 
brain is preparing to deal with vital autonomic functions such as 
breathing, required for the start of new life after birth. Trigeminal 
nucleus hypoplasia and variations in expression of SP in sud-
den perinatal death victims as compared to controls provide a 
possibility of revealing one of the underlying mechanisms in its 
pathophysiology.
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